The stock of Alphatec Holdings Inc (ATEC, Financial) experienced a notable decline, dropping by 5.24%. The share price reached $4.98 with a trading volume of 772,276 shares and a turnover rate of 0.55%, reflecting a price fluctuation of 4.86%.
In its recent financial report, ATEC recorded revenue of $146 million, a net loss of $40.68 million, and an earnings per share (EPS) of -$0.29. The company's gross profit stood at $82.72 million, resulting in a price-to-earnings (P/E) ratio of -3.74.
Among 12 rating institutions, 92% have advised to buy ATEC stock, with the remaining 8% suggesting a hold, and no agencies recommending a sell.
Within the medical devices sector, which saw an overall decline of 0.43%, related stocks such as Bone Biologics Corp, Beyond Air, Inc., and Nuwellis, Inc. showed significant gains. Meanwhile, Tenon Medical, Inc., Bone Biologics Corp, and Nuwellis, Inc. exhibited high turnover rates of 44.15%, 40.78%, and 22.44%, respectively. Bone Biologics Corp, Pavmed Inc C/Wts 30/04/2025 (To Pur Com) Class Z, and Adagio Medical Holdings, Inc. showed substantial price volatility with amplitude of 42.76%, 41.86%, and 28.77%, respectively.
Alphatec Holdings Inc is a medical technology firm specializing in the design, development, and improvement of products for surgical treatments related to spinal disorders, diseases, congenital deformities, and trauma. The company's spinal approach technologies include procedures such as posterior cervical fusion, anterior cervical discectomy fusion, lateral lumbar interbody fusion, and posterior lumbar interbody fusion.
